SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-21-073276
Filing Date
2021-03-08
Accepted
2021-03-08 16:30:57
Documents
2
Group Members
ARTAL GROUP S.A.ARTAL INTERNATIONAL MANAGEMENT S.A.ARTAL INTERNATIONAL S.C.A.ARTAL TREASURY LTDINVUS PUBLIC EQUITIES ADVISORS, LLCMR. AMAURY WITTOUCKSTICHTING ADMINISTRATIEKANTOOR WESTENDWESTEND S.A.

Document Format Files

Seq Description Document Type Size
1 SC 13G d152028dsc13g.htm SC 13G 149371
2 EX-1 d152028dex1.htm EX-1 11082
  Complete submission text file 0001193125-21-073276.txt   162318
Mailing Address VALLEY PARK 44, RUE DE LA VALLEE LUXEMBOURG N4 L-2661
Business Address VALLEY PARK 44, RUE DE LA VALLEE LUXEMBOURG N4 L-2661 352224259-1
Artal International Management S.A. (Filed by) CIK: 0001522131 (see all company filings)

IRS No.: 000000000 | State of Incorp.: N4 | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 399 BINNEY STREET, SUITE 300 CAMBRIDGE MA 02139
Business Address 399 BINNEY STREET, SUITE 300 CAMBRIDGE MA 02139 617-679-9600
Rubius Therapeutics, Inc. (Subject) CIK: 0001709401 (see all company filings)

IRS No.: 042688109 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90775 | Film No.: 21722366
SIC: 2836 Biological Products, (No Diagnostic Substances)